Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema

ClinicalTrials.gov ID: NCT01994291

Public ClinicalTrials.gov record NCT01994291. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 3:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Masked, Placebo-Controlled, Parallel Group, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist (PF-04634817) With That Of Ranibizumab In Adult Subjects With Diabetic Macular Edema

Study identification

NCT ID
NCT01994291
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
199 participants

Conditions and interventions

Interventions

  • Masked Sham Therapy Drug
  • PF-04634817 Drug
  • Placebo Drug
  • Ranibizumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2013
Primary completion
Jul 31, 2015
Completion
Jul 31, 2015
Last update posted
Oct 16, 2016

2013 – 2015

United States locations

U.S. sites
33
U.S. states
15
U.S. cities
28
Facility City State ZIP Site status
Retina Research Institute, LLC Phoenix Arizona 85014
Retinal Consultants of Arizona Phoenix Arizona 85014
Sunny View Medical Center Phoenix Arizona 85018
Premier Research Group Limited Phoenix Arizona 85027
Retina Centers, P.C. Tucson Arizona 85704
Retina Institute of California Arcadia California 91007
Retina Vitreous Associates Medical Group Beverly Hills California 90211
Retinal Diagnostic Center Campbell California 95008
Retina Associates of Orange County Laguna Hills California 92653
Southern California Desert Retina Consultants Palm Desert California 92211
American Institute of Research (Administrative Only) Whittier California 90603
New England Retina Associates New London Connecticut 06320
Bascom Palmer Eye Institute Miami Florida 33136
Fort Lauderdale Eye Institute Plantation Florida 33324
Center for Retina and Macular Disease Winter Haven Florida 33880
Southeast Retina Center, PC Augusta Georgia 30909
Midwest Eye Institute Indianapolis Indiana 46290
Tufts Medical Center Boston Massachusetts 02111
TLC Eyecare & Laser Center Jackson Michigan 49202
Wm Beaumont Medical Office Building Royal Oak Michigan 48073
Charlotte Eye Ear Nose and Throat Associates PA Charlotte North Carolina 28210
Retina Associates of Cleveland, Inc. Cleveland Ohio 44122
Retina Associates of Cleveland Youngstown Ohio 44505
Dean McGee Eye Institute Oklahoma City Oklahoma 73104
University of Oklahoma -OU Physicians Oklahoma City Oklahoma 73104
Retina Vitreous Consultants Pittsburgh Pennsylvania 15213
Associates in Ophthalmology Ltd West Mifflin Pennsylvania 15122
Black Hills Regional Eye Institute Rapid City South Dakota 57701
Brain B.Berger,MD,PA Austin Texas 78705
Retina Research Center Austin Texas 78705
Retina Consultants of Houston, PA Houston Texas 77030
Medical Center Ophthalmology Associates San Antonio Texas 78240
Rocky Mountain Retina Consultants Salt Lake City Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01994291, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2016 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01994291 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →